[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  TheBull [@TheBull_Stocks](/creator/twitter/TheBull_Stocks) on x 20.8K followers Created: 2025-07-22 14:53:58 UTC $REPL $XXXX filled a few! plummeted (-75%) $XXXXX to $XXXX on FDA response letter! Current Cash $8.19/share Replimune Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma. The Company will request a Type A meeting and expects it will be granted within XX days. Replimune plans to urgently interact with the FDA to find a path forward for the timely accelerated approval Possible Reversal Play! Manage Risks  XXXXXX engagements  **Related Topics** [repl](/topic/repl) [$819share](/topic/$819share) [$repl](/topic/$repl) [Post Link](https://x.com/TheBull_Stocks/status/1947671465639162326)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
TheBull @TheBull_Stocks on x 20.8K followers
Created: 2025-07-22 14:53:58 UTC
$REPL $XXXX filled a few! plummeted (-75%) $XXXXX to $XXXX on FDA response letter!
Current Cash $8.19/share
Replimune Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma.
The Company will request a Type A meeting and expects it will be granted within XX days. Replimune plans to urgently interact with the FDA to find a path forward for the timely accelerated approval
Possible Reversal Play! Manage Risks
XXXXXX engagements
/post/tweet::1947671465639162326